Advertisement
Screener

Dana Incorporated (DAN) Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

2.8 / 5 stars · 68/120 Roast Me

Dana Incorporated Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

Dana Incorporated (DAN) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $11.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-06

  • Dana Incorporated income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $11.00M.
  • Dana Incorporated income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$15.00M.
  • Dana Incorporated income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$37.00M.
  • Dana Incorporated income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $13.00M.
  • Dana Incorporated income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was -$53.00M.
  • Dana Incorporated income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$342.00M.
  • Dana Incorporated income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$262.00M.
  • Dana Incorporated income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2017 was $116.00M, a 82.24% decline from fiscal 2016.
Period endIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 monthIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 monthIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 monthIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month
2026-06-30$11.00M
10-Q · filed 2026-08-06
-$4.00M
10-Q · filed 2026-08-06
-$41.00M
derived: sum of 3 quarters · filed 2026-08-06
-$28.00M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$15.00M
10-Q · filed 2026-05-15
-$52.00M
derived: sum of 2 quarters · filed 2026-05-15
-$39.00M
derived: sum of 3 quarters · filed 2026-05-15
-$51.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$37.00M
10-K · filed 2026-02-27
-$24.00M
derived: sum of 2 quarters · filed 2026-02-27
-$36.00M
derived: sum of 3 quarters · filed 2026-08-06
-$53.00M
10-K · filed 2026-02-27
2025-09-30$13.00M
10-K · filed 2026-02-27
$1.00M
derived: sum of 2 quarters · filed 2026-08-06
-$16.00M
10-Q · filed 2025-10-31
-$211.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$12.00M
10-Q · filed 2026-08-06
-$29.00M
10-Q · filed 2026-08-06
-$224.00M
derived: sum of 3 quarters · filed 2026-08-06
-$245.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$17.00M
10-Q · filed 2026-05-15
-$212.00M
derived: sum of 2 quarters · filed 2026-05-15
-$233.00M
derived: sum of 3 quarters · filed 2026-05-15
-$294.00M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31-$195.00M
10-K · filed 2026-02-27
-$216.00M
derived: sum of 2 quarters · filed 2026-02-27
-$277.00M
derived: sum of 3 quarters · filed 2026-02-27
-$342.00M
10-K · filed 2026-02-27
2024-09-30-$21.00M
10-K · filed 2026-02-27
-$82.00M
derived: sum of 2 quarters · filed 2026-02-27
-$147.00M
10-Q · filed 2025-10-31
2024-06-30-$61.00M
10-K · filed 2026-02-27
-$126.00M
10-Q · filed 2025-08-11
2024-03-31-$65.00M
10-K · filed 2026-02-27
2023-12-31-$262.00M
10-K · filed 2026-02-27
2017-12-31$116.00M
10-K · filed 2018-02-14
2016-12-31$653.00M
10-K · filed 2018-02-14
2015-12-31-$83.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14
$39.00M
derived: sum of 2 quarters · filed 2018-02-14
$102.00M
derived: sum of 3 quarters · filed 2018-02-14
$176.00M
10-K · filed 2018-02-14
2015-09-30$122.00M
10-Q · filed 2015-10-22
$185.00M
derived: sum of 2 quarters · filed 2015-10-22
$259.00M
10-Q · filed 2015-10-22
$378.00M
derived: sum of 4 quarters · filed 2017-02-10
2015-06-30$63.00M
10-Q · filed 2015-07-23
$137.00M
10-Q · filed 2015-07-23
$256.00M
derived: sum of 3 quarters · filed 2017-02-10
$350.00M
derived: sum of 4 quarters · filed 2017-02-10
2015-03-31$74.00M
10-Q · filed 2015-04-23
$193.00M
derived: sum of 2 quarters · filed 2017-02-10
$287.00M
derived: sum of 3 quarters · filed 2017-02-10
$379.00M
derived: sum of 4 quarters · filed 2017-02-10
2014-12-31$119.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-10
$213.00M
derived: sum of 2 quarters · filed 2017-02-10
$305.00M
derived: sum of 3 quarters · filed 2017-02-10
$343.00M
10-K · filed 2017-02-10
2014-09-30$94.00M
10-Q · filed 2015-10-22
$186.00M
derived: sum of 2 quarters · filed 2015-10-22
$224.00M
10-Q · filed 2015-10-22
$268.00M
derived: sum of 4 quarters · filed 2016-02-18
2014-06-30$92.00M
10-Q · filed 2015-07-23
$130.00M
10-Q · filed 2015-07-23
$174.00M
derived: sum of 3 quarters · filed 2016-02-18
$246.00M
derived: sum of 4 quarters · filed 2016-02-18
2014-03-31$38.00M
10-Q · filed 2015-04-23
$82.00M
derived: sum of 2 quarters · filed 2016-02-18
$154.00M
derived: sum of 3 quarters · filed 2016-02-18
$251.00M
derived: sum of 4 quarters · filed 2016-02-18
2013-12-31$44.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-18
$116.00M
derived: sum of 2 quarters · filed 2016-02-18
$213.00M
derived: sum of 3 quarters · filed 2016-02-18
$261.00M
10-K · filed 2016-02-18
2013-09-30$72.00M
10-Q · filed 2014-10-23
$169.00M
derived: sum of 2 quarters · filed 2014-10-23
$217.00M
10-Q · filed 2014-10-23
$310.00M
derived: sum of 4 quarters · filed 2015-02-20
2013-06-30$97.00M
10-Q · filed 2014-07-24
$145.00M
10-Q · filed 2014-07-24
$238.00M
derived: sum of 3 quarters · filed 2015-02-20
$298.00M
derived: sum of 4 quarters · filed 2015-02-20
2013-03-31$48.00M
10-Q · filed 2014-04-25
$141.00M
derived: sum of 2 quarters · filed 2015-02-20
$201.00M
derived: sum of 3 quarters · filed 2015-02-20
$289.00M
derived: sum of 4 quarters · filed 2015-02-20
2012-12-31$93.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20
$153.00M
derived: sum of 2 quarters · filed 2015-02-20
$241.00M
derived: sum of 3 quarters · filed 2015-02-20
$315.00M
10-K · filed 2015-02-20
2012-09-30$60.00M
10-Q · filed 2013-10-29
$148.00M
derived: sum of 2 quarters · filed 2013-10-29
$222.00M
10-Q · filed 2013-10-29
$298.00M
derived: sum of 4 quarters · filed 2014-02-21
2012-06-30$88.00M
10-Q · filed 2013-07-25
$162.00M
10-Q · filed 2013-07-25
$238.00M
derived: sum of 3 quarters · filed 2014-02-21
$354.00M
derived: sum of 4 quarters · filed 2014-02-21
2012-03-31$74.00M
10-Q · filed 2013-04-25
$150.00M
derived: sum of 2 quarters · filed 2014-02-21
$266.00M
derived: sum of 3 quarters · filed 2014-02-21
2011-12-31$76.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21
$192.00M
derived: sum of 2 quarters · filed 2014-02-21
$240.00M
10-K · filed 2014-02-21
2011-09-30$116.00M
10-Q · filed 2012-10-26
$164.00M
10-Q · filed 2012-10-26
2010-12-31$36.00M
10-K · filed 2013-02-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
Versigent PLC (VGNT)$3.205B
VISTEON CORP (VC)United States$2.398B16.55
Dorman Products, Inc. (DORM)United States$3.641B18.26
Atmus Filtration Technologies Inc. (ATMU)United States$3.656B19.39
PHINIA INC. (PHIN)United States$2.197B22.60
PATRICK INDUSTRIES INC (PATK)United States$2.176B20.75
LCI INDUSTRIES (LCII)United States$2.034B12.21
Adient plc (ADNT)Ireland$1.311B29.53
Dauch Corp (DCH)United States$1.287B-7.80
GENTEX CORP (GNTX)United States$4.643B13.22